Tenofovir and its potential in the treatment of hepatitis B virus

Tenofovir and its potential in the treatment of hepatitis B virus

Laura Reynaud, Maria Aurora Carleo, Maria Talamo, Guglielmo BorgiaDepartment of Public Medicine and Social Security &ndash; Section of Infectious Disease University of Naples &ldquo;Federico II&rdquo;, ItalyAbstract: Recent literature is reviewed about treatment of chronic he...

Full description

Bibliographic Details
Main Authors:	Laura Reynaud, Maria Aurora Carleo, Maria Talamo, Guglielmo Borgia
Format:	Article
Language:	English
Published:	Dove Medical Press 2009-02-01
Series:	Therapeutics and Clinical Risk Management
Online Access:	http://www.dovepress.com/tenofovir-and-its-potential-in-the-treatment-of-hepatitis-b-virus-a2834

Similar Items

Treatment of Chronic Hepatitis B with Tenofovir
by: Mohsen Akhondi Meybodi, et al.
Published: (2018-07-01)

Tenofovir alafenamide for prevention and treatment of hepatitis B virus reactivation and de novo hepatitis
by: Kento Inada, et al.
Published: (2021-09-01)

Renal Concerns in the Treatment of Chronic Hepatitis B with Tenofovir
by: Giuseppe Coppolino, et al.
Published: (2017-03-01)

Tenofovir treatment of the severe acute hepatitis B Tratamiento con tenofovir de la hepatitis aguda B de evolución grave
by: Fernando Casals-Seoane, et al.
Published: (2013-01-01)

Differential binding of tenofovir and adefovir to reverse transcriptase of hepatitis B virus.
by: Formijn J van Hemert, et al.
Published: (2014-01-01)

Tenofovir alafenamide in the treatment of chronic hepatitis B virus infection: rationale and clinical trial evidence
by: Ruth Byrne, et al.
Published: (2018-07-01)

Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B infection
by: J Jones, et al.
Published: (2010-05-01)

Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B infection
by: J Jones, et al.
Published: (2010-05-01)

Tenofovir for children and adults with chronic hepatitis B
by: Li, Huijuan, et al.
Published: (2023)

Hepatitis B virus genotype is an independent prognostic factor of telbivudine and tenofovir treatment in hepatitis B surface antigen‐positive pregnant women
by: Baofang Zhang, et al.
Published: (2022-01-01)

Tenofovir in treatment of Iranian patients with chronic hepatitis B virus infection: An open-label case series
by: Behrooz Ataei, et al.
Published: (2016-01-01)

Case of Pregnant Hepatitis B Presenting with Hepatic Exacerbation After Cessation of Tenofovir Treatment
by: Yeliz ÖZEN
Published: (2017-12-01)

The Effect of Tenofovir Treatment on Renal Function in Chronic Hepatitis B Patients
by: Yusuf Kayar, et al.
Published: (2019-10-01)

Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
by: Hyeyeon Hong, et al.
Published: (2024-01-01)

Virological profiles of hepatitis B virus (HBV)-infected African patients treated with tenofovir
by: H.F. Njai, et al.
Published: (2014-04-01)

Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B
by: Young-Suk Lim, et al.
Published: (2023-10-01)

Cost–utility analysis of tenofovir disoproxil fumarate in the treatment of chronic hepatitis B
by: Dakin, H, et al.
Published: (2011)

Acquired Fanconi Syndrome from Tenofovir Treatment in a Patient with Hepatitis B
by: Shirley X. Jiang, et al.
Published: (2023-01-01)

Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B?
by: Hyung Joon Yim
Published: (2016-06-01)

Analogs in the treatment of chronic hepatitis B: real life experience with tenofovir and entecavir
by: Rosanna Villani, et al.
Published: (2015-06-01)

Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review
by: Borgia Guglielmo, et al.
Published: (2010-03-01)

Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B
by: Chan Ho Park, et al.
Published: (2016-03-01)

A novel piperazine derivative that targets hepatitis B surface antigen effectively inhibits tenofovir resistant hepatitis B virus
by: S. Kiruthika, et al.
Published: (2021-06-01)

Prophylactic effect of tenofovir on viral reactivation in immunocompromised pregnant women living with hepatitis B virus
by: Le Zhang, et al.
Published: (2022-09-01)

Comparison of Pegylated Interferon Alfa Therapy in Combination with Tenofovir Alafenamide Fumarate or Tenofovir Disoproxil Fumarate for Treatment of Chronic Hepatitis B Patients
by: He J, et al.
Published: (2023-06-01)

Non-Inferior Efficacy of Tenofovir Disoproxil to Tenofovir Disoproxil Fumarate in Virologically Suppressed Chronic Hepatitis B Patients
by: Yim HJ, et al.
Published: (2022-09-01)

Tenofovir in the Management of Chronic Hepatitis B Infection During Pregnancy
by: Yeşim Çekin, et al.
Published: (2012-06-01)

New approaches in the management of chronic hepatitis B: role of tenofovir
by: Jurri&euml;n GP Reijnders, et al.
Published: (2009-04-01)

Evaluation of the Efficacy of Entecavir and Tenofovir in the Treatment of Chronic Hepatitis B: A Retrospective Study
by: Arzu ŞENOL, et al.
Published: (2019-12-01)

Cost-effectiveness of tenofovir in the treatment of patients with chronic hepatitis B: data from literature
by: Massimo Fasano, et al.
Published: (2014-03-01)

Role of tenofovir and telbivudine in treatment of hepatitis B related acute on chronic liver failure
by: Debraj Malakar, et al.
Published: (2021-01-01)

[Tenofovir and entecavir for chronic hepatitis B infection treatment: a single-center experience]
by: Fabio Tarsetti, et al.
Published: (2015-12-01)

Observational study on the response of tenofovir monotherapy versus tenofovir plus telbivudine dual therapy in patients with hepatitis B virus related acute on chronic liver failure
by: Abul H Manik, et al.
Published: (2021-01-01)

Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection.
by: Yu-Shan Huang, et al.
Published: (2016-01-01)

Tenofovir vs. Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma after Radiofrequency Ablation
by: Zili Hu, et al.
Published: (2022-03-01)

Frequency of Hepatitis B Virus Resistance Mutations in Women Using Tenofovir Gel as Pre-Exposure Prophylaxis
by: Cheryl Baxter, et al.
Published: (2019-06-01)

Effectiveness and safety of tenofovir amibufenamide and its comparison with tenofovir alafenamide in patients with chronic hepatitis B: results from a retrospective real-world study
by: Lanqing Li, et al.
Published: (2023-06-01)

Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answer
by: Pin-Nan Cheng, et al.
Published: (2024-04-01)

A randomized open label trial of tenofovir monotherapy versus tenofovir plus telbivudine in spontaneous reactivation of hepatitis B
by: Ankur Jindal, et al.
Published: (2019-01-01)

Vertical transmission of hepatitis B virus: challenges and solutions
by: Gentile I, et al.
Published: (2014-06-01)